Global Menopause Market

Global Menopause Market Size, Share, Growth Analysis, By Applications(Screening and Diagnosis), By End User(Hospital, Diagnostic Centres) - Industry Forecast 2024-2031


Report ID: SQMIG35I2115 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 62 | Figures: 78

Global Menopause Market Dynamics

Menopause Market Drivers

  • There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.
  • The factors such as development of non-hormonal therapies, personalized medicine, and digital health solutions along with shifting trend towards natural and herbal remedies is anticipated to offer several opportunities for the market. Although hormone replacement therapy (HRT) has long been the main treatment for menopause symptoms, non-hormonal alternatives are becoming more and more popular. Pharmaceutical firms and healthcare professionals have a chance to develop efficient non-hormonal treatments for symptoms like hot flashes, vaginal dryness, and mood swings. Also, there is no one-size-fits-all approach to treatment for menopause because it affects women differently. The menopausal market may offer a sizable opportunity for personalized treatment that takes into account a woman's particular symptoms, medical history, and lifestyle. Moreover, telemedicine, wearable technology, and other digital health solutions could help women going through menopause. There is a chance to create digital health products that support women in tracking their symptoms, getting support and guidance, and communicating with medical professionals.
  • Furthermore, Education and Support are crucial to the market's expansion. Education and assistance for women going through menopause are desperately needed. Businesses that provide advocacy programs, support networks, and instructional resources could be very helpful in meeting this demand.

Menopause Market Restraints

  • Even though the market has significant potential to grow, the factors such as safety concerns, lack of awareness and stigma, regulatory hurdles, and limited research and development may hinder the market growth. Breast cancer, heart disease, and stroke risk have all been found to be higher in women who use hormone replacement therapy (HRT). As a result, there are now worries regarding the safety of HRT and a rising need for non-hormonal treatments. It may be difficult for businesses that specialize in hormone-based therapy to solve these safety issues. Menopause is still a taboo subject in many countries, and little is known and understood about it and how it affects women's health. This may reduce demand and make it challenging for businesses to properly promote menopause goods and services. Also, the menopausal market is governed by stringent regulatory standards, especially for hormone-based treatments. Prior to being licensed for use, new medications and therapies developed by companies must pass strict safety and efficacy requirements. However, there is still a lot to learn about menopause and how it affects women's health. The availability of efficient treatments and therapies could be hampered by the lack of research and development in the field. These are a few of the elements that can impede the market's expansion.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Menopause Market was valued at USD 16.9 Billion in 2022 and is poised to grow from USD 17.8 Billion in 2023 to USD 26.97 Billion by 2031, at a CAGR of 5.33% during the forecast period (2024-2031). 

With a wide range of businesses joining the market and creating new products and services to meet the demands of women going through menopause, the menopause market is getting more and more competitive. As the industry expands, competition is likely to heat up, forcing businesses to stand out via innovation, efficacy, and safety in order to gain market share. 'Pfizer Inc.', 'Novo Nordisk A/S', 'Allergan plc', 'TherapeuticsMD Inc.', 'Mylan N.V.', 'Teva Pharmaceutical Industries Ltd.', 'Bayer AG', 'Merck & Co. Inc.', 'Johnson & Johnson', 'GlaxoSmithKline plc', 'Eli Lilly and Company', 'Amgen Inc.', 'AbbVie Inc.', 'Pfizer Inc.', 'Novartis International AG', 'Procter & Gamble Co.', 'Roche Holding AG', 'Sanofi SA', 'Serenity Pharmaceuticals LLC', 'Mithra Pharmaceuticals SA', 'In May 2023, Astellas Pharma Inc. obtained approval from the FDA for VEOZAH, a groundbreaking nonhormonal neurokinin 3 (NK3) receptor antagonist. This marks the first-of-its-kind approval for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. ', 'In March 2023, Amyris, Inc. acquired MenoLabs, LLC, a company specializing in menopause treatment and research in this field. This strategic acquisition is poised to facilitate the expansion of Amyris, Inc.'s product portfolio in the realm of menopause treatments. ', 'In March 2022, Aptorum Group Limited, announced the highly anticipated commercial introduction of NativusWell®. This new dietary supplement is designed to support women's health during the various stages of menopause and is specifically targeted for the Chinese market. '

There are several factors driving the menopause market such as, aging population, rising awareness, lifestyle factors, and technological advancements. Also, Changing attitudes and Healthcare access and affordability are some of the other factors driving the market. As the global population ages, more women will enter menopause, leading to a larger market for menopause-related products and services. This demographic trend is expected to continue for the foreseeable future, as life expectancies increase and birth rates decline in many regions. For instance, The North American Menopause Association estimates that 2 million women in the United States experience menopause every year, or roughly 6,000 women every day. According to UN statistics, there will be 985 million women in 2020 who are 50 years of age or older. By 2050, this figure is anticipated to reach 1.65 billion. The market for menopause products has been significantly boosted by growing public knowledge of menopause and its symptoms. The changes that take place during menopause and the health hazards linked to it are becoming well known to women. The demand for goods and services that can assist manage menopause symptoms, like hormone therapy, herbal supplements, and lifestyle changes, has surged as a result of this raised awareness. Lifestyle factors, such as poor diet and lack of exercise, can exacerbate menopause symptoms and increase the demand for products and services that address these issues. Women are increasingly recognizing the importance of a healthy lifestyle during menopause, which has led to a growing market for products and services that promote wellness during this phase of life.

Owing to concerns about the potential hazards of hormone-based treatments, many women are searching for non-hormonal therapy to treat the symptoms of menopause. As a result, there is an increasing need for non-hormonal treatments such herbal medicines, CBT, and mindfulness-based treatments.

The North America region is anticipated to dominate the market for Menopause market. This dominance is owing to the large population of women undergoing menopause in North America, which increases demand for menopause-related goods and services. Also, compared to other markets, the North American market may have healthcare systems that are more advanced and greater access to these goods and services.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Menopause Market

Product ID: SQMIG35I2115

$5,300
BUY NOW GET FREE SAMPLE